Assessing Flu-specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion
Assessing Flu-specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion
批准号:
10088408
负责人:
Anoma Nellore
金额:
$22.28万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-01 至 2023-01-31
关键词:
AddressAdenovirus VectorAffinityAntibody FormationAntigensArteriesAttenuatedAvidityB-Cell Antigen ReceptorBindingBiological AssayBiological ModelsBiopsyBloodBrainBrain DeathBronchoscopyCardiopulmonaryCell surfaceCellsClinicalDataDoseEpitopesFamily suidaeFormulationFutureGasesGenerationsGoalsHarvestHeadHemagglutininHourHumanHumoral ImmunitiesImmuneImmune responseImmunityImmunoglobulin Somatic HypermutationImmunoglobulin-Secreting CellsIn SituInfectionInfluenzaKineticsKnowledgeLeft atrial structureLungLung diseasesLymph Node TissueLymphoidLymphoid TissueMediastinal lymph node groupMembraneMemoryMemory B-LymphocyteModalityModelingMucous MembraneMusMutationOrganOrgan DonorPerfusionPhenotypeRecombinant AntibodyRegimenResearchRespiratory SystemStructure of germinal center of lymph nodeStructure of parenchyma of lungSupport SystemTestingTimeTissue ViabilityTissuesTransgenesTransplantationVaccine DesignVaccinesVariantViralViruscell typechemokinecostdesignfluimmunogenicimmunoregulationinfluenza infectioninfluenza virus straininfluenzavirusinnovationlymphoid organpandemic diseasepandemic influenzapost-transplantresponseseasonal influenzauniversal influenza vaccineuniversal vaccineventilation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY. Broadly reactive humoral immune responses to flu protect against viral variants. Murine
data shows that the flu-specific memory B cells (Bmem) in the lung are cross-protective across a number of
influenza strains and are functionally distinct from circulating and lymphoid counterparts. As yet we do not know
if flu-specific Bmem in the human lung are cross-protective and bridging this knowledge gap is important to
design the appropriate vaccine regimens that are universally protective against flu. Flu-specific Bmem in ex vivo
lung tissues are rare and this represents a significant technical hurdle in assaying the flu-specific Bmem response
in human lung tissues. In order to address this technical hurdle, this application seeks to establish a model
system wherein human lung tissue is challenged with influenza virus and maintained viable after this challenge
on an advanced cardiopulmonary modality called Ex Vivo Lung Perfusion or EVLP. We anticipate this model will
allow us to enumerate and analyze the flu-specific Bmem response at scale in ex vivo human lung tissues. We
also anticipate that this model system will allow us to compare binding reactivity to viral variants between flu-
specific Bmem located in lung versus mediastinal lymph node tissues to define where cross-protective immunity
exists in the respiratory tract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金